Search results
Can-Fite BioPharma and Nutriband Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show...
Digital Journal· 3 days agoORLANDO, FL / ACCESSWIRE / May 10, 2024 / RedChip Companies will air interviews with Can-Fite BioPharma Ltd. (NYSE American:CANF) and Nutriband Inc. (NASDAQ:NTRB) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this
One Health Direct Increases Efforts And Patient Education for Phototherapy Treatment
WKBN 27 Youngstown· 7 days agoOne Health Direct (OHD) leadership has continuously recognized and focused on the importance of implementing patient product awareness and eligibility education of innovative DME products for ...
Soligenix to Present at Upcoming Conferences
FOX 23 News Albany· 7 days agoSoligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an ...
Takeda tackles $900m restructuring plan after generics hurt annual profits
Pharmaceutical Technology via Yahoo Finance· 4 days agoThese programs involve therapies to treat rare blood disorders, psoriasis and neurological...
Takeda profit slumps by half as Japanese drugmaker rebuilds pipeline
WSAU Wausau· 4 days agoTOKYO (Reuters) - Japan's Takeda Pharmaceutical said full-year earnings slumped by more than half as...
Immunic advances ‘potentially groundbreaking’ MS therapy vidofludimus calcium during Q1
Proactive Investors· 5 days agoImmunic Inc (NASDAQ:IMUX) continued to advance its clinical programs for its lead drug asset,...
Japan's Takeda Pharma to restructure after annual profit slump
Reuters· 4 days ago, opens new tab announced a restructuring on Thursday after annual profit slid by more than half...
Biotech Breakthroughs: 7 Stocks Driving the Next Wave in Healthcare
InvestorPlace· 5 days agoInvestors concerned about broader market undulations may want to consider the resilience narrative...
Q1 2024 Nektar Therapeutics Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 3 days agoAdditionally, REZPEG was well-tolerated and treatment with REZPEG did not induce anti-drug antibodies in patients, which has been reported with some examples in the IL-2 mutein ...
Against Sunscreen Absolutism
The Atlantic· 3 days agoThe country’s predominantly white population has by far the world’s highest rate of skin cancer, and for years the public-health establishment has warned...
